Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 1:194:28-31.
doi: 10.1016/j.drugalcdep.2018.09.020. Epub 2018 Oct 25.

Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014

Avik Chatterjee  1 , Marc R Larochelle  2 , Ziming Xuan  3 , Na Wang  4 , Dana Bernson  5 , Michael Silverstein  6 , Scott E Hadland  7 , Thomas Land  5 , Jeffrey H Samet  8 , Alexander Y Walley  9 , Sarah M Bagley  10
Affiliations

Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014

Avik Chatterjee et al. Drug Alcohol Depend. .

Abstract

Background: Opioid-related overdoses and deaths among adolescents in the United States continue to increase, but little is known about adolescents who experience opioid-related non-fatal overdose (NFOD). Our objective was to describe (1) the characteristics of adolescents aged 11-17 who experienced NFOD and (2) their receipt of medications for opioid use disorder (MOUD) in the 12 months following NFOD, compared with adults.

Methods: We created a retrospective cohort using six Massachusetts state agency datasets linked at the individual level, with information on 98% of state residents. Individuals entered the cohort if they experienced NFOD between January 1, 2012 and December 31, 2014. We compared adolescents to adults experiencing NFOD, examining individual characteristics and receipt of medications for opioid use disorder (MOUD)-methadone, buprenorphine, or naltrexone.

Results: Among 22,506 individuals who experienced NFOD during the study period, 195 (0.9%) were aged 11-17. Fifty-two percent (102/195) of adolescents were female, whereas only 38% of adults were female (P < 0.001). In the year prior to NFOD, 11% (21/195) of adolescents received a prescription opioid, compared to 43% of adults (P < 0.001), and <5% (<10/195) received any MOUD compared to 23% of adults (P < 0.001). In the 12 months after NFOD, only 8% (15/195) of adolescents received MOUD, compared to 29% of adults.

Conclusion: Among individuals experiencing NFOD, adolescents were more likely to be female and less likely to have been prescribed opioids in the year prior. Few adolescents received MOUD before or after NFOD. Non-fatal overdose is a missed opportunity for starting evidence-based treatment in adolescents.

Keywords: Adolescents; Opioid use disorder; Overdose.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No conflict declared.

References

    1. Bagley SM, Hadland SE, Carney BL, Saitz R, 2017. Addressing stigma in medication treatment of adolescents with opioid use disorder. J. Addict. Med. 11, 415–416. 10.1097/ADM.0000000000000348. - DOI - PubMed
    1. Balousek S, Plane MB, Fleming M, 2007. Prevalence of interpersonal abuse in primary care patients prescribed opioids for chronic pain. J. Gen. Intern. Med. 22, 1268–1273. 10.1007/s11606-007-0257-6. - DOI - PMC - PubMed
    1. Bourgois P, Prince B, Moss A, 2004. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Hum. Organ. 63, 253–264. https://doi.Org/10.1016/j.bbi.2008.05.010. - DOI - PMC - PubMed
    1. Center for Behavioral Health Statistics and Quality, 2015. Results from the 2014 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration, Center for Behvioral Health Statistics and Quality, Rockville, MD: https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs2014/NSDUH-....
    1. Cicero TJ, Ellis MS, Kasper ZA, 2017. Increased use of heroin as an initiating opioid of abuse. Addict. Behav 74, 63–66. https://doi.Org/10.1016/j.addbeh.2017.05.030. - DOI - PubMed

Publication types

Substances